The abstract is read at the publisher; the summary is JClub's.
Lipid-rich malignant ascites suppresses ovarian cancer–associated T-cell function by driving a cholesterol-efflux and incomplete fatty-acid-oxidation transcriptomic program linked to impaired plasma-membrane signaling.
- Why it matters: Malignant ascites is immunosuppressive and limits locoregional BiTE therapy, but how ascites lipids mechanistically impair antitumor T-cell activity is unclear.
- What they did: T cells were transcriptomically profiled after exposure to acellular ascites fluid, and anti-CD3/CD28 stimulation plus lipid depletion were used to test effects on lipid accumulation and signalling.
- The result: In coculture with ovarian cancer cells and an EpCAM-targeting BiTE, ascites abolished T-cell activation and tumor killing, while lipid depletion restored activation, IFN-γ production, and BiTE-mediated cytotoxicity.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.